Lv4
420 积分 2026-04-09 加入
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
3天前
已完结
Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015–2022)
3天前
求助中
Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review
3天前
已完结
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study
4天前
已关闭
Long duration of immunotherapy before radiosurgery might improve intracranial control of melanoma brain metastases
5天前
已关闭
A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations
5天前
已完结
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
5天前
已完结
Management outcomes for biopsy-proven radiation necrosis in patients with brain metastases in the era of immune-checkpoint blockade
5天前
已完结
Evaluating of radiation-induced cerebral contrast enhancements in brain metastases: analysis of incidence and risk predictors
5天前
已完结
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
5天前
已完结
皖公网安备34019202002308
